OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS® powered with SOPHiA DDM™. The organization, which currently uses the SOPHiA [...]

Highly Accurate Long-Read Sequencing Data Will Be Used At Novogene’s New Lab In Munich, Supporting Customers Across A Network Of Leading Research Institutions MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its [...]

News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competitor capillary DSC technologiesi. Streamlines thermal stability testing of biologics using disposable microfluidic chips (MFCs) enabling analysis under actual high-concentration drug dosing and use conditions. Delivers faster and more accurate measurements of high-concentration [...]

Boston – Labguru (Biodata Inc.), a leading provider of laboratory data management solutions, has integrated its Labhandy mobile app with Brady Corp, a world leader in high-performance identification solutions. This strategic collaboration transforms on-the-go labeling for lab professionals, offering the ability to print labels anytime and anywhere, enhancing precision and efficiency. Labhandy’s mobile app complements Labguru's lab data management platform by enabling [...]

Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024 HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today provides an overview of advances supporting the Company’s overall corporate strategy to [...]

The teams aim to redefine plasmid sequencing with nanopore technology and global accessibility OXFORD, England, & LOS ANGELES -- Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based company that introduced overnight whole-plasmid sequencing, today announced an expanded, multi-year contract and a collaboration aimed [...]

CINCINNATI, OHIO – The life science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announces its comprehensive suite of eco-conscious, cost-effective innovations tailored for diagnostic assay developers. Committed to advancing the sustainability goals of the in vitro Diagnostics (IVD) industry, Meridian has developed cutting-edge solutions that minimize waste, [...]

London, UK — PCR Biosystems, a leading developer of PCR reagents, have launched a range of advanced inhibitor-tolerant mixes for probe-based qPCR and 1-step RT-qPCR. Available in the Clara® and Air-Dryable product lines, these new mixes feature innovative broad-spectrum inhibitor-tolerant chemistry, guaranteeing reliable and highly sensitive DNA and RNA detection with even the most challenging [...]

The organizations are collaborating to deliver an integrated AI experience for high throughput experimentation (HTE) Toronto, CANADA and Lausanne, Switzerland —ACD/Labs, an informatics company that develops and commercializes software in support of R&D, and Atinary Technologies, a pioneer company that offers a no-code platform and self-driving labs technology for AI-driven innovation, announce a partnership to fast-track [...]

Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing SANTA CLARA, California -- Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules [...]